IDEAYA Biosciences promotes Michael White to president of R&D
Bitget2026/09/28 10:01- IDEAYA Biosciences promoted Michael White to president, research and development, effective Sept. 28, 2026.
- White was chief scientific officer since 2021.
- He previously served as Pfizer’s chief scientific officer, head of tumor biology, leading oncology small-molecule pipeline development.
- Earlier, he was a UT Southwestern professor, founding director of the Cancer Intervention and Prevention Discovery Program.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.
US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening
Amaero, a manufacturer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has gone public on the US stock market.
Crypto prices
More
